DCGI approved DRDO developed anti-COVID drug for emergency use
The Drugs Controller General of India (DCGI) has granted permission for emergency use of anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) developed by INMAS, DRDO. Daily Current Affairs Quiz 2021 The Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr. Reddy’s Laboratories […]
DCGI approved DRDO developed anti-COVID drug for emergency use Read More »










